Greater Manchester Medicines Management Group

images courtesy of NHS Photo Library

NHS logo

GMMMG Consultations

 

On this page you will find proposed changes that are currently going through the GMMMG approval process. This will include consultations on proposed RAG status, updated Formulary Chapters, Pathways or other GMMMG Guidance. You will be able to comment on current proposals via the links in the table below.

Due to the COVID-19 outbreak all active GMMMG consultations were temporarily suspended in April. The active consultations have now been re-opened; please see below for the new end dates. Every effort has been made to allow sufficient time for appropriate clinical input to these documents, but if you foresee any problems or have any questions please email nuth.enquires.gmmmg@nhs.net

Title

Information

Feedback

End date

93

HCDS - PsA and AS Pathway Outcome Monitor

The following PsA and AS Pathway Outcome Monitor is now available for consultation. Please submit your comments here. This consultation closes at 5pm on Friday 14th August

Feedback Form

5pm Friday
14th August 2020

92

HCDS - PsA Pathway
(this is a zipped file)

The following PsA Pathway is now available for consultation. Please submit your comments here. This consultation closes at 5pm on Friday 14th August

Feedback Form

5pm Friday
14th August 2020

91

HCDS - AS Pathways
(this is a zipped file)

The following AS Pathway is now available for consultation. Please submit your comments here. This consultation closes at 5pm on Friday 14th August

Feedback Form

5pm Friday
14th August 2020

90

FMESG actions for June 2020

The following FMESG actions for June 2020 have been proposed. We now seek comments on these proposals.  This consultation is open until 5pm on Friday 14th August.

Feedback Form

5pm Friday
14th August 2020

89

FMESG - Greater Manchester Joint Wound Care Formulary

On behalf of the GMMMG Formulary and Managed Entry Subgroup, an updated Greater Manchester Joint Wound Care Formulary is in development. Adoption of the updated formulary is underway within GM Trusts.  We now seek the comments on this draft from primary care and community services.  This consultation period is open until 5pm Friday 10th July 2020

Feedback Form

5pm Friday
10th July 2020

88

PaGDSG - SCP for Azathioprine for IBD in paediatrics [link removed - consultation closed]

On behalf of the GMMMG Pathways and Guidelines Development Subgroup, an updated Greater Manchester wide shared care protocol for Azathioprine for IBD in paediatrics [link removed - consultation closed] is in development. We now seek comments [link removed - consultation closed] on this draft. This consultation period is open until 5pm on Monday 29th June 2020.

Feedback Form
[link removed - consultation closed]

5pm Monday
29th June 2020

87

PaGDSG - SCP for Ethinylestradiol and estradiol for the induction of delayed puberty [link removed - consultation closed]

On behalf of the GMMMG Pathways and Guidelines Development Subgroup, an updated  Greater Manchester wide shared care protocol for Ethinylestradiol and estradiol for the induction of delayed puberty [link removed - consultation closed] is in development. We now seek comments [link removed - consultation closed] on this draft. This consultation period is open until 5pm on Monday 29th June 2020.

Feedback Form
[link removed - consultation closed]

5pm Monday
29th June 2020

<< Back

Line

TERMS AND CONDITIONS    |    CONTACT US    |    ABOUT US    |    ARCHIVE

RSS Feed
 
spacer